Aesthetic Injectables Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$7500
Buy Report Download FREE Resources

Published: June 15, 2026 Report Code: GDME581MM-ST

Select Item

Explore the aesthetic injectables market size, market share, segment forecasts, company rankings and country-level trends to 2036.

Assess the global aesthetic injectables market with GlobalData’s interactive market model, covering market size, revenue, intervention volumes, product usage, average selling prices, company market shares and forecasts from 2015 to 2036. Aesthetic injectables, including products used for wrinkle reduction, facial volume restoration and contouring, are an important segment of the medical aesthetics industry. As demand for minimally invasive cosmetic procedures evolves, manufacturers, investors and commercial leaders need reliable data to evaluate growth opportunities, understand competitive positioning and prioritise markets.

Built on GlobalData’s proprietary database, this model combines quantitative market estimates, primary research, key opinion leader perspectives and relevant real-world data sources. It covers 39 countries and includes country-specific insights into healthcare systems, reimbursement policies and medical device regulation. Use the model to support decisions across commercial strategy, portfolio planning, geographic expansion and investment.

  • Evaluate market growth: Analyse historical performance and forecasts through 2036 to inform strategic planning and resource allocation.
  • Identify segment opportunities: Compare market value, intervention volumes, units and average selling prices to assess differences in segment performance.
  • Benchmark competitors: Examine company market shares and rankings, where available, alongside competitive dynamics and SWOT analysis.
  • Prioritise geographic expansion: Compare 39 country markets to assess market conditions and identify locations for further commercial evaluation.
  • Support pricing and portfolio strategy: Use segment-level data to inform pricing reviews, product positioning and portfolio planning.
  • Assess market access: Review country-specific regulatory frameworks, reimbursement policies and healthcare systems to identify considerations for market entry.
  • Inform investment decisions: Use market forecasts and competitive intelligence to support acquisition screening, due diligence and partnership assessments.

Scope

Delivered as an interactive Excel spreadsheet, the model provides historical data, forecasts and analyst commentary across the following areas.

  • Market Size, Revenue and Forecasts: Analyse annual market revenue by segment from 2015 to 2036, alongside market value, units, intervention volumes, average selling prices and product usage. These insights help you assess historical performance and evaluate future market opportunities.

  • Company Market Share and Competitive Landscape: Examine currently marketed aesthetic injectable products, company market shares and rankings where available, as well as competitive dynamics, industry trends and SWOT analysis. Companies covered include Allergan Aesthetics, Galderma SA, Merz Pharma GmbH & Co. KGaA, Sinclair Pharma Ltd, Teoxane SA and other market participants.

  • Country-Level Market Analysis Across 39 Countries: The model covers markets across North America, Europe, Asia-Pacific, Latin America, the Middle East and Africa. Countries include the United States, United Kingdom, Germany, France, China, India, Japan, Australia, Brazil, Canada, Saudi Arabia and the United Arab Emirates, among others. Country-level models include sourced market data, epidemiology-based indications, intervention volumes and analyst commentary, enabling comparisons of market scale and segment performance.

  • Regulatory, Reimbursement and Market Access Analysis: Assess country-specific healthcare systems, reimbursement policies and medical device regulatory frameworks. This information helps you understand local market access requirements and evaluate considerations that may affect market entry or expansion.

Key Highlights

The report is delivered as an interactive Excel spreadsheet that covers value, volume, product usage, average selling prices, market size, and company share/rank analysis (wherever available). It covers 39 key countries within the aesthetic injectables market; each of the 39 covered countries, includes color-coded, fully sourced market models equipped with epidemiology-based indications and intervention volumes. Moreover, analyst comments with qualitative insights offer context for the quantitative data.

Key inclusions of the market model are:

    • Currently marketed aesthetic injectables and the evolving competitive landscape.

    • Insightful reviews of key industry trends.

    • Annualized total aesthetic injectables market revenue by segment, along with market outlooks from 2015 to 2036.

    • Granular data on total interventions, units, average selling prices, and market values by segment.

Global, regional, and country-level market-specific insights:

    • Qualitative market-specific information is available, with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique, country-specific insights on the market.

    • SWOT analysis for the aesthetic injectables market.

    • Competitive dynamics insights and trends are provided for the aesthetic injectables market.

Drive your understanding of the market by capturing the complete picture, including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape:

    • Country-specific overview of the healthcare system.

    • Country-specific reimbursement policies.

    • Country-specific MedTech regulatory landscape.

Reasons to Buy

The report is designed for professionals making commercial, strategic and investment decisions in medical aesthetics.

  • CMOs and Marketing Directors: Evaluate market opportunities, competitor positioning and geographic marketing priorities.

  • Commercial Directors and Sales Leaders: Prioritise markets and segments for sales planning and resource allocation.

  • Product Managers and Portfolio Strategy Teams: Assess segment performance and competitive positioning to support portfolio decisions.

  • Business Development and Corporate Strategy Leaders: Evaluate expansion opportunities, licensing arrangements, acquisitions and partnerships.

  • Market Intelligence Teams: Monitor market developments and provide evidence-based competitive assessments.

  • Regulatory Affairs and Market Access Professionals: Review country-level regulatory and reimbursement considerations.

  • Procurement and Sourcing Leaders: Assess the competitive supply landscape where relevant to sourcing decisions.

  • Private Equity Firms and Investment Analysts: Support investment screening and commercial due diligence using market forecasts and competitive data.

How Companies Can Use This Report

The following examples illustrate potential applications of the market model. They do not imply that these companies currently use GlobalData’s research or follow the strategies described.

  • Allergan Aesthetics: Assess company market shares, segment performance and competitive dynamics to inform portfolio reviews and commercial planning.

  • Galderma: Compare country-level forecasts, intervention volumes and average selling prices to support geographic prioritisation and sales planning.

  • Merz Aesthetics: Evaluate segment-level market trends and competitive positioning to identify areas for further commercial assessment.

  • Sinclair and Teoxane: Compare country markets and review regulatory and reimbursement considerations to inform market-entry assessments.

  • Private Equity and Corporate Development: Use market forecasts and competitive analysis to evaluate the attractiveness of potential investments and identify areas requiring further due diligence.

Access the Aesthetic Injectables Market Forecast to 2036

Whether you are reviewing your product portfolio, benchmarking competitors, evaluating new markets or assessing an investment, GlobalData’s market model provides data to support your analysis.

Explore the report and request a sample to assess its coverage against your business priorities before purchasing the full model.

Allergan Aesthetics
Galderma SA
Merz Pharma GmbH & Co KgaA
Sinclair Pharma Ltd
Teoxane SA
Others
Aesthetic Injectables Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 standard reports
Currency USD
$7,500

Can be used by individual purchaser only

Most Popular
$15,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$22,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Aesthetic Injectables Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Aesthetic Devices reports
Medical Devices
New
Regulatory Approved Apps Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | September 2026
Medical Devices
New
Non-Invasive Ventilation Masks and Circuits Market Size by Segments, Share,…
$7,500 | September 2026
Medical Devices
New
Insulin Pumps and Continuous Glucose Monitors Market Size by Segments,…
$7,500 | September 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Aesthetic Injectables Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 in real time.

  • Access a live Aesthetic Injectables Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more